Inovio Pharmaceuticals (INO) Selling, General & Administrative (2010 - 2026)
Inovio Pharmaceuticals (INO) reported Selling, General & Administrative of $7.8 million for Q2 2026, down 8.9% from $8.56 million a year earlier and down 1.0% from the prior quarter.
Powered by 
Analysis
Inovio Pharmaceuticals (INO) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Inovio Pharmaceuticals' Selling, General & Administrative came in at $30.77 million, down 9.0% year-over-year; for FY2025, it was $32.68 million, down 11.7% from FY2024.
- Selling, General & Administrative has declined for three consecutive years, with a five-year compound annual growth rate of -2.6% (FY2020 to FY2025).
- By year, Selling, General & Administrative came in at $37 million in FY2024 (-22.2%), $47.58 million in FY2023 (-47.2%), $90.19 million in FY2022 (+67.8%) and $53.75 million in FY2021 (+44.3%).
- Five-year quarterly Selling, General & Administrative spans a low of $7.22 million in Q4 2025 and a high of $48.46 million in Q2 2022.
- Year over year, Selling, General & Administrative has now declined in each of the last 16 quarters, with an average decline of 13.1% over the last eight quarters.
- The high point for year-over-year Selling, General & Administrative in five years was Q2 2022 (growth of 282.6%); the low point was Q2 2023 (a decline of 72.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $7.88 million (Q1 2026), $7.22 million (Q4 2025) and $7.88 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Inovio Pharmaceuticals | 94.68 Mn | 94.68 Mn | - | 7.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.80 Mn |
| Mar 31, 2026 | 7.88 Mn |
| Dec 31, 2025 | 7.22 Mn |
| Sep 30, 2025 | 7.88 Mn |
| Jun 30, 2025 | 8.56 Mn |
| Mar 31, 2025 | 9.02 Mn |
| Dec 31, 2024 | 7.60 Mn |
| Sep 30, 2024 | 8.61 Mn |
| Jun 30, 2024 | 10.21 Mn |
| Mar 31, 2024 | 10.57 Mn |
| Dec 31, 2023 | 10.24 Mn |
| Sep 30, 2023 | 9.93 Mn |
| Jun 30, 2023 | 13.52 Mn |
| Mar 31, 2023 | 13.89 Mn |
| Dec 31, 2022 | 13.95 Mn |
| Sep 30, 2022 | 11.82 Mn |
| Jun 30, 2022 | 48.46 Mn |
| Mar 31, 2022 | 15.95 Mn |
| Dec 31, 2021 | 14.05 Mn |
| Sep 30, 2021 | 13.16 Mn |
API Access
Inovio Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=INO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();